Vertebral Fracture Risk After Once-Weekly Teriparatide Injections: Follow-Up Study of Teriparatide Once-Weekly Efficacy Research (TOWER) Trial

Current Medical Research and Opinion - United Kingdom
doi 10.1185/03007995.2012.761956